Banca Mediolanum (BMED) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Achieved record net income of €1.238 billion in 2025, up 11% year-over-year, with strong core profitability, commercial momentum, and robust business fundamentals.
Net commission income rose 12% to €1.313 billion, supported by strong managed asset inflows and high-quality service.
Customer base expanded 6% to over 2 million, with continued growth in Family Banker and Private Banker networks.
Proposed a €1.25 per share dividend, up 25% from 2024, including a base of €0.80 and a portion from non-recurring items.
Extraordinary €2,000 bonus awarded to all employees and Family Bankers for 2025 performance.
Financial highlights
Total net inflows reached €11.64 billion (+11%), with managed asset inflows up 18% to €9.06 billion.
Total assets under administration increased 12% to €155.8 billion; credit book expanded to €18.98 billion (+8%).
Loans granted surged 28% to €3.96 billion; general insurance gross premiums grew 20% to €246.4 million.
Cost/income ratio improved to 37.6%, below the 40% target.
Net Non-Performing Exposures ratio at 0.77%; CET1 ratio at 23.0%.
Outlook and guidance
2026 guidance: net inflows into managed assets targeted at €9 billion, assuming normal markets.
Net interest income expected to rise about 10% versus 2025, with cost/income ratio around 38%.
Cost of risk projected at 20 bps; base dividend per share to increase from €0.80.
Latest events from Banca Mediolanum
- Net income up 24% to EUR 449.9M, assets under administration EUR 129.5B, CET1 at 23.7%.BMED
Q2 20242 Feb 2026 - Net income up 18% to €674.3M, with record assets and higher interim dividend.BMED
Q3 202415 Jan 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 10% YoY, record inflows, and strong capital ratios support 2025 outlook.BMED
Q1 20258 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20251 Nov 2025